NO179163C - Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse - Google Patents

Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse

Info

Publication number
NO179163C
NO179163C NO872991A NO872991A NO179163C NO 179163 C NO179163 C NO 179163C NO 872991 A NO872991 A NO 872991A NO 872991 A NO872991 A NO 872991A NO 179163 C NO179163 C NO 179163C
Authority
NO
Norway
Prior art keywords
preparation
release drug
sustained release
sustained
drug
Prior art date
Application number
NO872991A
Other languages
English (en)
Norwegian (no)
Other versions
NO872991D0 (no
NO872991L (no
NO179163B (no
Inventor
Hidenobu Andoh
Sumio Watanabe
Yasuo Miyake
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO872991D0 publication Critical patent/NO872991D0/no
Publication of NO872991L publication Critical patent/NO872991L/no
Publication of NO179163B publication Critical patent/NO179163B/no
Publication of NO179163C publication Critical patent/NO179163C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO872991A 1986-07-18 1987-07-17 Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse NO179163C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤

Publications (4)

Publication Number Publication Date
NO872991D0 NO872991D0 (no) 1987-07-17
NO872991L NO872991L (no) 1988-01-19
NO179163B NO179163B (no) 1996-05-13
NO179163C true NO179163C (no) 1996-08-21

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872991A NO179163C (no) 1986-07-18 1987-07-17 Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse

Country Status (13)

Country Link
US (1) US5030455A (fr)
EP (1) EP0254978B1 (fr)
JP (1) JPH0816066B2 (fr)
KR (1) KR960004857B1 (fr)
AT (1) ATE71291T1 (fr)
CA (1) CA1309656C (fr)
DE (1) DE3775850D1 (fr)
DK (1) DK174931B1 (fr)
ES (1) ES2040228T3 (fr)
FI (1) FI96095C (fr)
GR (1) GR3003536T3 (fr)
NO (1) NO179163C (fr)
PH (1) PH25286A (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
SG43833A1 (en) * 1993-12-13 1997-11-14 Lidak Pharmaceuticals Sucrose ester-c20 to c25 alcohol formulations
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
AU713580B2 (en) * 1995-09-25 1999-12-02 Merial Ltd Anthelmintic macrocyclic lactone compositions
CA2252055C (fr) * 1996-04-11 2007-01-16 The University Of British Columbia Liposomes entrainant une fusion
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법
PT1448235E (pt) * 2001-11-30 2007-05-31 Pfizer Prod Inc Composições farmacêuticas orais de libertação controlada de 5,8,14-triazatetraciclo ( 10.3.1.0(2,11).0(4,9) ) - hexadeca-2(11),3,5,7,9-pentaeno.
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
KR101532920B1 (ko) * 2010-12-08 2015-07-01 아이다 엔지니어링, 엘티디. 고강도 소결성형체의 제조방법 및 그 제조장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DE3569080D1 (en) * 1984-08-30 1989-05-03 Rodisma Pharma Prod Gmbh Process for sustaining the release of vitamins c and e

Also Published As

Publication number Publication date
KR960004857B1 (ko) 1996-04-16
FI96095C (fi) 1996-05-10
CA1309656C (fr) 1992-11-03
ES2040228T3 (es) 1993-10-16
DE3775850D1 (de) 1992-02-20
ATE71291T1 (de) 1992-01-15
DK373187D0 (da) 1987-07-17
NO872991D0 (no) 1987-07-17
FI96095B (fi) 1996-01-31
GR3003536T3 (fr) 1993-03-16
FI873106A0 (fi) 1987-07-14
US5030455A (en) 1991-07-09
FI873106A (fi) 1988-01-19
JPH0816066B2 (ja) 1996-02-21
NO872991L (no) 1988-01-19
EP0254978B1 (fr) 1992-01-08
EP0254978A1 (fr) 1988-02-03
JPS6327439A (ja) 1988-02-05
PH25286A (en) 1991-04-30
KR880001301A (ko) 1988-04-22
NO179163B (no) 1996-05-13
DK174931B1 (da) 2004-03-01
DK373187A (da) 1988-01-19

Similar Documents

Publication Publication Date Title
NO179163C (no) Fremgangsmåte for fremstilling av et legemiddelpreparat med forlenget frigivelse
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
DE58906894D1 (de) Einrichtung zur diagnostik und behandlung von nasenerkrankungen.
GB8501015D0 (en) Drug
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
DE69025920T2 (de) Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
FI875245A (fi) Foerfarande foer oekande av utsoendringen av adenosin.
FI873083A (fi) Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
ES2059588T3 (es) Factor xiii para la prevencion de una hemorragia intraventricular.
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
KR900012933A (ko) 당뇨병 및 과혈당증 치료제로 유용한 화합물 및 이의 제조방법
ATE109137T1 (de) Pyridinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3583234D1 (de) Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
DE3876425T2 (de) Gesteuerte verabreichung eines heilmittels an blut.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
ES2063784T3 (es) Procedimiento para la preparacion de derivados de pirrolizina.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
DK417889D0 (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
FR2619110B1 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR2630114B2 (fr) Derives de (piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
FR2630113B2 (fr) Derives de ((piperidinyl-4)methyl)-2 tetrahydro-1,2,3,4 isoquinoleine, leur preparation et leur application en therapeutique
OA08184A (fr) Agents anti-hypertentifs, compositions pharmaceutiques les contenant et procédé de préparation desdits agents et compositions.
IT1075255B (it) Procedimetno per estrarre l'eme-gruppo prostetico ferroso dell'emoglobina dagli scarti risultanti dalla purificazione delle proteine contenute nel sangue

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: JK THORSENS PATENTBUREAU AS, POSTBOKS 9276 GRONLAN

MK1K Patent expired